A Cu(II) complex targeting the translocator protein: in vitro and in vivo antitumor potential and mechanistic insights
View/
Date
2016-12-01Metadata
Show full item recordUsage
This item's downloads: 269 (view details)
Cited 19 times in Scopus (view citations)
Recommended Citation
Montagner, D., Fresch, B., Browne, K., Gandin, V., & Erxleben, A. (2017). A Cu(ii) complex targeting the translocator protein: in vitro and in vivo antitumor potential and mechanistic insights. Chemical Communications, 53(1), 134-137. doi: 10.1039/C6CC08100B
Published Version
Abstract
A new Cu-based anticancer metallodrug which targets the translocator protein is reported. [CuBr2(TZ6)] elicits a remarkable in vitro cytotoxicity in sensitive and multidrug resistant cell lines and induces a 98% reduction of tumor mass in a murine tumor model. Target binding was studied by experimental and computational methods.
Collections
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Ireland